QCast: Data-Driven Dialogue in Drug Development podcast

Episode 72: Group Sequential Designs in Clinical Trials

0:00
9:43
Rewind 15 seconds
Fast Forward 15 seconds

In this QCast episode, co-hosts Jullia and Tom discuss group sequential designs in clinical trials, where pre-planned interim analyses allow a study to stop early for efficacy, stop for futility, or continue to the next look.

Key Takeaways

  • Interim looks are usually timed by information fraction, the share of planned statistical information collected so far. A look is only worth including if its result would change a decision.
  • Stopping boundaries such as Oโ€™Brienโ€“Fleming and Pocock set different evidence thresholds at each look. Alpha spending keeps the overall false-positive risk controlled across all planned analyses.
  • A design can look attractive on paper and still need an implausible treatment effect to cross its first boundary. Clean, timely data and controlled access to interim results matter as much as the statistics.


๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.

About Quanticate

Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:

  • Clinical Data Capture & Management
  • Biostatistics & Statistical Consultancy
  • Statistical Programming & PK/PD Analysis
  • Medical Writing & Pharmacovigilance
  • Regulatory & Submission Support
  • AI & Automation
  • Post-Marketing Safety & Real-World Data

Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

More episodes from "QCast: Data-Driven Dialogue in Drug Development"